Clinical Trial Update: Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis. [NA]

View source ↗

Summary

A clinical trial comparing non-selective beta blockers to endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Drugs mentioned

• Non-selective beta-blockers

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Hepatocellular Carcinoma With Portal Vein Thrombosis | NA | Status: WITHDRAWN